Related Experiment Videos
Reduced DHPRα1S and RyR1 expression levels are associated with diaphragm contractile dysfunction during sepsis
Guang-Yu Jiao1, Li-Ying Hao, Chun-E Gao
1Respiratory Department and Intensive Care Unit, Shengjing Hospital of China Medical University, Shenyang, Postal Code, 110004, People's Republic of China.
Muscle & Nerve
|August 15, 2013
Summary
Sepsis impairs diaphragm function by reducing key proteins, dihydropyridine receptors (DHPRα1s) and ryanodine receptors (RyR1), essential for muscle contraction. This study investigates their expression changes during sepsis.
Area of Science:
- Physiology
- Molecular Biology
- Pathology
Background:
- Sepsis commonly leads to diaphragm dysfunction.
- Dihydropyridine receptors (DHPRα1s, DHPRα1c) and ryanodine receptors (RyR1, RyR2, RyR3) are critical for muscle excitation-contraction coupling.
- Receptor expression in the diaphragm during sepsis remains unexplored.
Purpose of the Study:
- To investigate the expression of DHPRs and RyRs in the diaphragm during sepsis.
- To determine the relationship between receptor expression and diaphragm contractile function in sepsis.
Main Methods:
- Sepsis was induced in rats using endotoxin.
- Diaphragm isometric contractile force was measured.
- mRNA and protein levels of DHPRs and RyRs in diaphragm muscles were quantified.
Main Results:
- Sepsis significantly reduced diaphragm contractile function.
- Expression of DHPRα1s and RyR1 (skeletal muscle isoforms) was significantly lower in septic rats.
- DHPRα1c and RyR3 expression remained unchanged; RyR2 was undetectable.
Conclusions:
- Reduced diaphragm contraction in sepsis is linked to decreased expression of DHPRα1s and RyR1.
- These findings highlight specific molecular changes contributing to sepsis-induced diaphragm dysfunction.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Acute Respiratory Failure-IV
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: